权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Developing robust treatment options for Mal de Débarquement Syndrome

开发针对 Mal de Débarquement 综合征的稳健治疗方案

基本信息

批准号：
10677732
负责人：
SERGEI YAKUSHIN
金额：
$ 47.5万
依托单位：
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-08-05 至 2027-05-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10677732
关键词：
Address Affective Aftercare Back Chronic Chronic Disease Clinical Cognitive Complementary therapies Controlled Study Coupled Custom Data Dedications Devices Disease Disorientation Dizziness Esthesia Exposure to Follow-Up Studies Force of Gravity Foundations Frequencies Head Health Services Accessibility Home Hour Improve Access Intervention Laboratories Medial Methods Motion Motion Sickness Movement New York City Outcome Patients Photic Stimulation Physiological Placebos Predisposition Protocols documentation Randomized Recurrence Reporting Self Perception Shapes Side Signs and Symptoms Space Perception Symptoms Syndrome Telemedicine Testing Transportation Travel Treatment Effectiveness Treatment Protocols Treatment outcome Vision Visual Visual Fields Visual Motion clinical practice cost desensitization design efficacy evaluation efficacy testing equilibration disorder experience follow-up habituation improved improved outcome motion sensitivity patient screening pilot test portability recruit reduce symptoms success symptomatic improvement symptomatology vestibulo-ocular reflex virtual reality virtual reality headset visual stimulus

项目摘要

ABSTRACT: Mal de Débarquement Syndrome (MdDS) is an under-recognized but nevertheless common balance disorder, which in most cases occurs after exposure to prolonged passive motion. MdDS, a chronic illness that can last for many years, is manifested by persistent false sensations of rocking/swaying or gravitational pull. MdDS is debilitating as these symptoms and signs are typically accompanied by other presumably secondary physical, cognitive, and affective problems. In addition to motion-triggered (MT) cases, the same or indistinguishable symptoms can occur without a specific trigger, identified as spontaneous-onset (SO) MdDS. Treatment options for MdDS are limited, and it was only recently that a breakthrough was made in our clinical laboratory with physiological readaptation of the vestibulo-ocular reflex (VOR). The premise of this treatment is that MdDS is caused by maladaptation of a functional component of the VOR called velocity storage, which shapes spatial orientation and the perception of self-motion. The treatment has been administered by maneuvering the head of the patient seated inside a cylindrical chamber during a full-field optokinetic stimulation (OKS). Our current success rates immediately after treatment of MT and SO MdDS are 75% and 50%, respectively. A follow-up study indicated that the success rates later fluctuate as well as that a significant number of patients remain sensitive to bright lights, movements of visual objects, and transportation, pointing to the treatment method's limitations. A primary hurdle is access to the treatment. Full-field OKS requires a specialized set-up in a dedicated room, making the treatment possible only in several laboratories around the world. We recently successfully pilot tested the efficacy of virtual reality (VR) goggles for MdDS treatment with the readaptation approach. In this proposed project, VR goggles will be tested on a larger group of patients, and the effects will be compared to those of full-field OKS. If proven to be effective, MdDS can be treated locally to patients in many vestibular therapy offices, not only for initial treatment but also for remedial or follow-up treatment when symptoms return. This proposal also addresses the weaknesses of the VOR readaptation approach by testing complementary approaches. We hypothesize that reducing (habituating) the velocity storage capacity decreases sensitivity to physical movement and improves MdDS symptoms as well as limits symptom recurrence. We further hypothesize that desensitization to visual stimuli can reduce visually induced dizziness frequently observed in patients with MdDS. We will verify whether these complementary treatments will provide a better outcome compared to the readaptation treatment by itself. Lastly, we hypothesize that OKS without head motion can reduce the false sensation of gravitational pull commonly reported by MdDS patients. Two hundred MdDS patients will be recruited for the study. Patients will be treated for 1-2 hours a day for 5 days. Patients will be followed up with for up to 12 months. The proposed study will facilitate improved outcomes for MdDS by broadening its treatment options.

摘要：mds是一种常见但未被充分认识的疾病